More forecasts: Atlanta 30 day forecast
University of Georgia's Intranasal COVID-19 Vaccine CVXGA Set for Clinical Trials in Fall
Jun 20, 2024
The University of Georgia's intranasal COVID-19 vaccine, CVXGA, is set for clinical trials with 10,000 participants to compare its effectiveness to current mRNA vaccines. Developed by UGA start-up CyanVac, it uses a modified parainfluenza virus.












